OCA
Octagon Capital Advisors’s Gossamer Bio GOSS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $22.6M | Hold |
18,350,000
| – | – | 4.95% | 6 |
|
2025
Q1 | $20.2M | Hold |
18,350,000
| – | – | 3.91% | 7 |
|
2024
Q4 | $16.6M | Buy |
18,350,000
+9,162,117
| +100% | +$8.29M | 2.73% | 14 |
|
2024
Q3 | $9.06M | Hold |
9,187,883
| – | – | 1.41% | 19 |
|
2024
Q2 | $8.28M | Hold |
9,187,883
| – | – | 1.3% | 18 |
|
2024
Q1 | $10.8M | Hold |
9,187,883
| – | – | 1.3% | 23 |
|
2023
Q4 | $8.38M | Buy |
9,187,883
+1,000,000
| +12% | +$913K | 1.34% | 19 |
|
2023
Q3 | $6.82M | Buy |
8,187,883
+4,229,814
| +107% | +$3.52M | 1.05% | 17 |
|
2023
Q2 | $4.75M | Buy |
3,958,069
+2,000,000
| +102% | +$2.4M | 0.66% | 28 |
|
2023
Q1 | $2.47M | Hold |
1,958,069
| – | – | 0.36% | 30 |
|
2022
Q4 | $4.25M | Sell |
1,958,069
-87,373
| -4% | -$190K | 0.66% | 24 |
|
2022
Q3 | $24.5M | Sell |
2,045,442
-712,627
| -26% | -$8.54M | 4.23% | 5 |
|
2022
Q2 | $23.1M | Buy |
2,758,069
+194,931
| +8% | +$1.63M | 6.16% | 5 |
|
2022
Q1 | $22.2M | Buy |
2,563,138
+1,050,000
| +69% | +$9.11M | 4.81% | 6 |
|
2021
Q4 | $17.1M | Hold |
1,513,138
| – | – | 3.33% | 11 |
|
2021
Q3 | $19M | Buy |
1,513,138
+100,000
| +7% | +$1.26M | 4.68% | 7 |
|
2021
Q2 | $11.5M | Hold |
1,413,138
| – | – | 2.38% | 14 |
|
2021
Q1 | $13.1M | Sell |
1,413,138
-150,000
| -10% | -$1.39M | 4.92% | 6 |
|
2020
Q4 | $15.1M | Buy |
+1,563,138
| New | +$15.1M | 5.24% | 8 |
|